Tempus AI Gross Profit 1970-1969 | TEM

Tempus AI annual/quarterly gross profit history and growth rate from 1970 to 1969. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Tempus AI gross profit for the quarter ending December 31, 1969 was $0M, a NAN% increase year-over-year.
  • Tempus AI gross profit for the twelve months ending December 31, 1969 was $0M, a NAN% increase year-over-year.
  • Tempus AI annual gross profit for was $0B, a NAN% decline from .
  • Tempus AI annual gross profit for was $0B, a NAN% decline from .
  • Tempus AI annual gross profit for was $0B, a NAN% decline from .
Tempus AI Annual Gross Profit
(Millions of US $)
Tempus AI Quarterly Gross Profit
(Millions of US $)
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.082B $0.000B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.979B 19.75
Hims & Hers Health (HIMS) United States $4.300B 0.00
Inspire Medical Systems (INSP) United States $4.021B 0.00
Axonics (AXNX) United States $3.439B 0.00
IRhythm Technologies (IRTC) United States $3.247B 0.00
Olink Holding AB (publ) (OLK) Sweden $3.145B 0.00
Azenta (AZTA) United States $2.808B 157.88
Enovis (ENOV) United States $2.463B 18.26
10x Genomics (TXG) United States $2.365B 0.00
Privia Health (PRVA) United States $2.043B 114.13
Schrodinger (SDGR) United States $1.414B 0.00
Phreesia (PHR) United States $1.215B 0.00
Omnicell (OMCL) United States $1.206B 41.70
Standard BioTools (LAB) United States $0.656B 0.00
Clover Health Investments (CLOV) United States $0.645B 0.00
Definitive Healthcare (DH) United States $0.625B 0.00
Fulgent Genetics (FLGT) United States $0.601B 0.00
Talkspace (TALK) United States $0.394B 0.00
Health Catalyst (HCAT) United States $0.357B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.303B 0.00
Pulmonx (LUNG) United States $0.239B 0.00
Outset Medical (OM) United States $0.214B 0.00
Butterfly Network (BFLY) United States $0.183B 0.00
P3 Health Partners (PIII) United States $0.179B 0.00
TruBridge (TBRG) United States $0.152B 8.19
American Well (AMWL) United States $0.111B 0.00
EUDA Health Holdings (EUDA) Singapore $0.103B 0.00
111 (YI) China $0.093B 0.00
SHL Telemedicine (SHLT) Israel $0.078B 0.00
HeartBeam (BEAT) United States $0.066B 0.00
MSP Recovery (LIFW) United States $0.066B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.045B 0.00
Augmedix (AUGX) United States $0.042B 0.00
Zepp Health (ZEPP) China $0.036B 0.00
Akili (AKLI) United States $0.034B 0.00
CareCloud (CCLD) United States $0.032B 0.00
Streamline Health Solutions (STRM) United States $0.030B 0.00
Movano (MOVE) United States $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Syra Health (SYRA) United States $0.009B 0.00
Biotricity (BTCY) United States $0.009B 0.00
Transgenomic (PRPO) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00